Director, President and CEO · BioCardia, Inc. · Common Stock
Side
BUY
Value
$1,030
Shares
1,000
Price
$1.03
Executed
Sep 29, 2026
Disclosed
Sep 30, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 29 executedSep 30, 2026 disclosed
BCDA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · BCDA
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Altman Peter filed this Form 4 reporting a open-market purchase of BCDA on Sep 29, 2026. It became public on Sep 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Altman Petercik:0001647542
Issuer
BioCardia, Inc.cik:0000925741
Revision history · 0
No field has changed since this record was first ingested.
